Literature DB >> 23845260

Porous silicon advances in drug delivery and immunotherapy.

David J Savage1, Xuewu Liu, Steven A Curley, Mauro Ferrari, Rita E Serda.   

Abstract

Biomedical applications of porous silicon include drug delivery, imaging, diagnostics and immunotherapy. This review summarizes new silicon particle fabrication techniques, dynamics of cellular transport, advances in the multistage vector approach to drug delivery, and the use of porous silicon as immune adjuvants. Recent findings support superior therapeutic efficacy of the multistage vector approach over single particle drug delivery systems in mouse models of ovarian and breast cancer. With respect to vaccine development, multivalent presentation of pathogen-associated molecular patterns on the particle surface creates powerful platforms for immunotherapy, with the porous matrix able to carry both antigens and immune modulators.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23845260      PMCID: PMC3795885          DOI: 10.1016/j.coph.2013.06.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  43 in total

Review 1.  Molecular-targeted nanotherapies in cancer: enabling treatment specificity.

Authors:  Elvin Blanco; Angela Hsiao; Guillermo U Ruiz-Esparza; Matthew G Landry; Funda Meric-Bernstam; Mauro Ferrari
Journal:  Mol Oncol       Date:  2011-10-25       Impact factor: 6.603

2.  Reorienting our view of particle-based adjuvants for subunit vaccines.

Authors:  Steven R Little
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 3.  Nanomedicine(s) under the microscope.

Authors:  Ruth Duncan; Rogerio Gaspar
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

Review 4.  Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.

Authors:  Christina K Baumgartner; Laurent P Malherbe
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

5.  Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody.

Authors:  Luo Gu; Laura E Ruff; Zhengtao Qin; Maripat Corr; Stephen M Hedrick; Michael J Sailor
Journal:  Adv Mater       Date:  2012-06-12       Impact factor: 30.849

6.  Cellular association and assembly of a multistage delivery system.

Authors:  Rita E Serda; Aaron Mack; Merlyn Pulikkathara; Ana Maria Zaske; Ciro Chiappini; Jean R Fakhoury; Douglas Webb; Biana Godin; Jodie L Conyers; Xue W Liu; James A Bankson; Mauro Ferrari
Journal:  Small       Date:  2010-06-21       Impact factor: 13.281

7.  Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles.

Authors:  Rita E Serda; Aaron Mack; Anne L van de Ven; Silvia Ferrati; Kenneth Dunner; Biana Godin; Ciro Chiappini; Matthew Landry; Louis Brousseau; Xuewu Liu; Andrew J Bean; Mauro Ferrari
Journal:  Small       Date:  2010-10-18       Impact factor: 13.281

8.  Tailored porous silicon microparticles: fabrication and properties.

Authors:  Ciro Chiappini; Ennio Tasciotti; Jean R Fakhoury; Daniel Fine; Lee Pullan; Young-Chung Wang; Lianfeng Fu; Xuewu Liu; Mauro Ferrari
Journal:  Chemphyschem       Date:  2010-04-06       Impact factor: 3.102

9.  Electrically conductive and optically active porous silicon nanowires.

Authors:  Yongquan Qu; Lei Liao; Yujing Li; Hua Zhang; Yu Huang; Xiangfeng Duan
Journal:  Nano Lett       Date:  2009-12       Impact factor: 11.189

10.  Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

Authors:  François Ghiringhelli; Pierre E Puig; Stephan Roux; Arnaud Parcellier; Elise Schmitt; Eric Solary; Guido Kroemer; François Martin; Bruno Chauffert; Laurence Zitvogel
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

View more
  9 in total

1.  Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies.

Authors:  Kelsey R Beavers; Thomas A Werfel; Tianwei Shen; Taylor E Kavanaugh; Kameron V Kilchrist; Jeremy W Mares; Joshua S Fain; Carrie B Wiese; Kasey C Vickers; Sharon M Weiss; Craig L Duvall
Journal:  Adv Mater       Date:  2016-07-06       Impact factor: 30.849

Review 2.  Embracing nanomaterials' interactions with the innate immune system.

Authors:  Abraham J P Teunissen; Marianne E Burnett; Geoffrey Prévot; Emma D Klein; Daniel Bivona; Willem J M Mulder
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-04-13

3.  Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns.

Authors:  Jimin Guo; Henning De May; Stefan Franco; Achraf Noureddine; Lien Tang; C J Brinker; Donna F Kusewitt; Sarah F Adams; Rita E Serda
Journal:  Nat Biomed Eng       Date:  2021-11-01       Impact factor: 29.234

4.  Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.

Authors:  Iman K Yazdi; Matthew B Murphy; Christopher Loo; Xuewu Liu; Mauro Ferrari; Bradley K Weiner; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2014-05-19       Impact factor: 7.813

5.  Co-localization and confinement of ecto-nucleotidases modulate extracellular adenosine nucleotide distributions.

Authors:  Hadi Rahmaninejad; Tom Pace; Shashank Bhatt; Bin Sun; Peter Kekenes-Huskey
Journal:  PLoS Comput Biol       Date:  2020-06-25       Impact factor: 4.475

6.  Mesoporous Silicon Particles Favor the Induction of Long-Lived Humoral Responses in Mice to a Peptide-Based Vaccine.

Authors:  Gabriela Navarro-Tovar; Denisse Rocha-García; Alejandra Wong-Arce; Gabriela Palestino; Sergio Rosales-Mendoza
Journal:  Materials (Basel)       Date:  2018-06-26       Impact factor: 3.623

Review 7.  Recent Developments in Porous Silicon Nanovectors with Various Imaging Modalities in the Framework of Theranostics.

Authors:  Jing Qian; Huang Wen; Konstantin Tamarov; Wujun Xu; Vesa-Pekka Lehto
Journal:  ChemMedChem       Date:  2022-03-18       Impact factor: 3.540

8.  Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin nanoliposomes.

Authors:  Ismail M Meraz; Claire H Hearnden; Xuewu Liu; Marie Yang; Laura Williams; David J Savage; Jianhua Gu; Jessica R Rhudy; Kenji Yokoi; Ed C Lavelle; Rita E Serda
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

9.  Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model.

Authors:  Dave Lumen; Simo Näkki; Surachet Imlimthan; Elisavet Lambidis; Mirkka Sarparanta; Wujun Xu; Vesa-Pekka Lehto; Anu J Airaksinen
Journal:  Pharmaceutics       Date:  2019-12-17       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.